Reference
European Medicines Agency. Strengthened guidance on follow-up and risk management for ATMP developers. Internet Document : 2 Feb 2018. Available from: URL: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2018/02/news_detail_002897.jsp&mid=WC0b01ac058004d5c1
Rights and permissions
About this article
Cite this article
Revised guideline for advanced therapy medicinal products. Reactions Weekly 1689, 4 (2018). https://doi.org/10.1007/s40278-018-41873-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-41873-3